4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000007
President & COO sold 1,826 shares at $12.32 ($22,499)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dowden Nathan J President & COO | 2024-03-06 | Sale 10b5-1 | −1,826 | $12.32 | $22,499 | 137,204 | D |
| Open-market sales · 1,826 sh · avg $12.32 · $22,499 | |||||||
Loading xslF345X05/wk-form4_1709933649.xml…